InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: StealthGold post# 177970

Monday, 08/09/2021 3:31:11 AM

Monday, August 09, 2021 3:31:11 AM

Post# of 232721
The idea that the USA FDA is dictating to other countries Regulatory Agencies against Leronlimab is so extremely unlikely as to be the farthest fetched notion ever. CYDY ran two Phase 2 trials in USA approved by USA FDA. They have the money to run 2 Phase 3 trials. The best CRO available was the Albert Einstein Hospital Group in Brazil which also had the most patients for the trials. They chose wisely Brazil over USA or the Philippines or anywhere else. If the Brazil trials prove the hypothesis generated by the Phase 2 trial Leronlimab will be golden in the eyes of the US FDA and everybody else including Big Pharma.
Anyone that remembers the way everybody and their dog talked about and wanted Cisco Systems shares in 1999 might see a repeat of that after CYDY is generating boatloads of cash from Covid, TNBC and HIV. And rightly so as Leronlimab has the potential in so many areas of medicine that deal with CCR5 and inflammation that it could be such a critical piece of the puzzle in medicine as Cisco switches and modems were to the Internet.
Why on earth else would there be the greatest of kerfuffles over CYDY? Because it is perceived to be the greatest potential disruptor in medicine. The great kerfuffle over the drug A2-73 and the SigmaOne receptor while maybe the greatest amount of kerfuffle before this Leronlimab and CCR5 kerfuffle pales in magnitude to the CYDY battle. Because although blarcamesine is a "pearl of inestimable value" and immense potential in CNS unmet need Leronlimab could be "the whole pearl bed of inestimable pearls" in many of the most chronic and pernicious afflictions that involve inflammation and dysfunctional immune response including ALZ.
BTW the baby bio that owns blarcamesine finally shot up recently 20X to above $25 from a low at $1.26 in Dec 2018 after being share price suppressed for many years under the kurfuffle mantra "Fire CEO Missling".
Sound familiar? Exact same tactics are being used against CYDY but with even louder and shriller fervor.
Don't blink!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News